Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design

Discovery and optimization of highly ligand-efficient oxytocin receptor antagonists using structure-based drug design Selective Nonpeptidic Fluorescent Ligands for Oxytocin Receptor: Design, Synthesis, and Application to Time-Resolved FRET Binding Assay Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1 a receptors Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs Structure-Based Discovery of Novel Chemotypes for Adenosine A_2AReceptor Antagonists Discovery of Potent Ligands for Estrogen Receptor β by Structure-Based Virtual Screening Structure-Based Design and Discovery of New M₂Receptor Agonists Computer-Aided Design and Synthesis of 5-Substituted Tryptamines and Their Pharmacology at the 5-HT1D Receptor: Discovery of Compounds with Potential Anti-Migraine Properties Vinblastine and vincristine are inhibitors of monoamine oxidase B Structure-Based Design of Glycosylated Oxytocin Analogues with Improved Selectivity and Antinociceptive Activity